Israeli members of Dignitas described aid-in-dying as control over a body they felt had already failed them
The interview material places aid-in-dying in Switzerland at the center of a deeply personal decision-making process shaped by chronic illness, disability, isolation, and prior suicidal thinking. Eleven Israelis who were members of the Swiss nonprofit Dignitas and had contemplated traveling to Switzerland for assisted death described a framework in which suffering was judged not by outsiders, but by the person living inside it. Their accounts were gathered through in-depth, semi-structured interviews and analyzed using grounded theory, a qualitative approach designed to build concepts from the patient’s own language rather than impose a predefined model.
A recurring thread across the interviews was the sense that prolonged dying could become a burden not only to the person experiencing it, but also to family members who would be forced to watch the decline unfold. For these participants, the appeal of traveling to Switzerland lay in the certainty of the outcome. They contrasted what they called a “beautiful death” with what they saw as “disadvantaged dying,” a term that captured fear of dependency, deterioration, and the loss of control that can accompany serious illness near the end of life.
Chronic illness, disability, and social isolation framed the wish to leave on one’s own terms
Seven themes emerged from the interviews: health and functioning; feelings regarding survivorship and existence; interacting with the health sector; attitudes regarding death and dying; suicide; choosing death; and choosing suicide tourism. Those themes map closely onto the lived reality of patients whose bodies no longer offer stability or predictability. Most participants referred to chronic illness, functional disability, and social isolation, a combination that can compress a person’s world until future time feels more like an obligation than a gift.
Some participants had experienced suicidal thoughts, and several had attempted suicide before, in some cases more than once. In a clinical sense, that history matters because it shows that the desire for aid-in-dying did not arise in a vacuum. The decision-making sat at the intersection of psychiatric vulnerability, physical suffering, and a long-standing conviction that the current trajectory could no longer be made acceptable.
One sentence in the findings cuts through the abstraction: suffering was understood as subjective, knowable only to the person who lives it. That perspective is central to the ethics of end-of-life care, because it places the patient’s own appraisal of suffering above external judgments about whether life remains worth preserving.
The Swiss option was valued for certainty, not for geography
The choice of Switzerland was not about attachment to place. Most participants did not see any deep emotional or civil meaning in dying in a foreign country. Instead, Switzerland represented a regulated route to a predictable death, one that stood in contrast to the uncertainty of natural decline. For people who fear erosion of autonomy, certainty can carry enormous moral weight.
Their comments also revealed an ambivalent relationship with family presence at the end of life. Many did not necessarily want loved ones beside them when they died. That preference should not be mistaken for detachment. It may instead reflect a wish to spare relatives the burden of witnessing the final stage of suffering, or a desire to keep the most intimate act of self-determination separate from roles shaped by dependency and obligation.
The emotional logic is stark. A controlled ending can appear kinder than a prolonged one when the disease process is experienced as relentless, humiliating, or isolating.
Suicide, survivorship, and the health sector were entwined in the participants’ narratives
Interviews touched repeatedly on interactions with the health sector, suggesting that participants did not experience medicine as an uncontested source of relief. The narrative of choosing death emerged alongside narratives of choosing suicide tourism, indicating that some participants located their decision outside the traditional clinician-patient framework. This is an important clinical distinction. For patients who have long felt unheard, medical systems may be seen less as a refuge than as another place where autonomy is negotiated, delayed, or denied.
The study’s qualitative design does not estimate prevalence, predict behavior, or measure outcomes. It does, however, capture how a specific group reasons about aid-in-dying when suffering is framed as irreversible and deeply personal. The participants’ language also exposes a practical contradiction at the heart of the Swiss model: the process offers controlled death, but only through a formalized, paid, and bureaucratic pathway that requires cooperation, documentation, and institutional approval.
That contradiction sits uneasily beside the idea of an entirely individual choice. A person seeking complete control over the end of life must still pass through organizational gates and depend on a nonprofit’s decision.
Dignitas approval became part of the moral drama
The conclusion centers on the paradox built into suicide tourism. Approval from Dignitas could feel desirable, even liberating, because it would confirm the possibility of a deliberate and controlled death. Refusal could feel tragic for the same reason, closing off the route that the participant had come to see as the most humane exit from suffering.
The emotional force of that paradox is easy to miss if the discussion stays at the level of policy. In these interviews, the request for aid-in-dying carried both existential and administrative meaning. Participants were not simply asking to die; they were asking for a recognized pathway through which suffering could be converted into a managed event. The payment, paperwork, and institutional formality did not erase the desire for autonomy. They made it visible.
For clinicians, ethicists, and policymakers, the study offers a close look at why some patients may view travel for assisted death as preferable to a drawn-out terminal course. It also shows how easily autonomy can become entangled with dependence on outside institutions, especially when people already feel detached from ordinary social and medical support. The study does not resolve whether such pathways should exist. It does show that for these Israeli Dignitas members, the wish for aid-in-dying in Switzerland was inseparable from illness burden, prior suicidality, and a belief that only the person suffering can truly define the limits of tolerable life.